Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Chay Ngee Lim being referenced
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies
2015
Short‐term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Chay Ngee Lim | 213 | 125 | 165 | 11 | 311 | |
| R F James | 189 | 94 | 231 | 14 | 345 | |
| Masahiko Miyagi | 232 | 93 | 86 | 14 | 301 | |
| Andy Joe Seelam | 135 | 71 | 91 | 8 | 280 | |
| Koichiro Nabe | 129 | 108 | 154 | 15 | 275 | |
| M. M. C. Landgraf-Leurs | 180 | 76 | 116 | 19 | 347 | |
| James D. Bomboy | 190 | 127 | 128 | 11 | 326 | |
| Diana Avram | 108 | 155 | 108 | 14 | 318 | |
| Ritsuko Yamamoto | 152 | 174 | 89 | 14 | 370 | |
| H. Katz | 178 | 73 | 144 | 13 | 331 | |
| Prashant Nadkarni | 108 | 125 | 84 | 9 | 358 |
All Works
Login with ORCID to disown or claim papers
Loading papers...